Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells: a novel predictor of morbidity among hemodialysis patients.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 11053488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the Dialysis Membrane on Mortality of Chronic Hemodialysis Patients. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agadoa L. Kidney International 1996, 50:566–570

  2008cited by this paper
• Generalized Linear Models

  2002cited by this paper
• Acute-phase proteins and other systemic responses to inflammation.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Immunologic function and survival in hemodialysis patients.

  1998cited by this paper
• Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

  1998cited by this paper
• Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients.

  1998cited by this paper
• Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

  1998cited by this paper
• Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.

  1997cited by this paper
• Vascular endothelial dysfunction.

  1997cited by this paper
• Effect of the dialysis membrane on mortality of chronic hemodialysis patients.

  1996cited by this paper
• Atherosclerosis: an update.

  1996cited by this paper
• Endotoxin: possible roles in initiation and development of atherosclerosis.

  1996influential reference
• Impact of single use versus reuse of cellulose dialyzers on clinical parameters and indices of biocompatibility.

  1996cited by this paper
• Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque

  1995cited by this paper
• Cytokine production in patients on dialysis.

  1995cited by this paper
• Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations.

  1995cited by this paper
• Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.

  1995cited by this paper
• Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis.

  1994cited by this paper
• Clinical comparison of high-flux cellulose acetate and synthetic membranes.

  1994cited by this paper
• Production of cytokines and cytokine inhibitory proteins in patients on dialysis.

  1994cited by this paper
• Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production.

  1994cited by this paper
• Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.

  1994cited by this paper
• Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

  1994cited by this paper
• Should Hemodialysis Fluid Be Sterile?

  1993cited by this paper
• Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

  1993cited by this paper
• Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.

  1993cited by this paper
• Gene expression of interleukin-1β during hemodialysis

  1993cited by this paper
• Gene expression of interleukin-1 beta during hemodialysis.

  1993cited by this paper
• The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.

  1992cited by this paper
• In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD.

  1992cited by this paper
• Generalized Linear Models (2nd ed.)

  1992cited by this paper
• Cytokines: agents provocateurs in hemodialysis?

  1992cited by this paper
• Pyrogen retention by the polyamide membranes.

  1992cited by this paper
• Lipopolysaccharide induces human interleukin‐1 receptor antagonist and interleukin‐1 production in the same cell

  1992cited by this paper
• Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

  1991cited by this paper
• Impaired Function of Macrophage Fcγ Receptors in End-Stage Renal Disease

  1990cited by this paper
• Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

  1990cited by this paper
• Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.

  1990cited by this paper
• The effect of membrane characteristics on tumour necrosis factor kinetics during haemodialysis.

  1990cited by this paper
• An analysis of gestational age, neonatal size and neonatal death using nonparametric logistic regression.

  1990cited by this paper
• Impaired function of macrophage Fc gamma receptors in end-stage renal disease.

  1990cited by this paper
• Effect of renal replacement therapy on cellular cytokine production in patients with renal disease.

  1990cited by this paper
• Functional changes of monocytes due to dialysis membranes.

  1989cited by this paper
• Isolation and characterization of a tumor necrosis factor binding protein from urine

  1989cited by this paper
• Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate.

  1988cited by this paper
• Association for the Advancement of Medical Instrumentation

  1988cited by this paper
• Blood-membrane interaction in hemodialysis leads to increased cytokine production.

  1987cited by this paper
• Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes.

  1987cited by this paper
• Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis.

  1987cited by this paper
• Induction of tumor necrosis factor during extracorporeal blood purification.

  1987cited by this paper

• Association Between Oxidative–Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case–Control Study

  2025cites this paper
• Pathology of catheter-related complications: what we need to know and what should be discovered

  2022cites this paper
• Monocytes in Uremia

  2020cites this paper
• Inflammation in Chronic Kidney Disease

  2020cites this paper
• Effects and immune responses of probiotic treatment in ruminants.

  2019cites this paper
• Analysis of IL1 gene polymorphisms and transcript levels in periodontal and chronic kidney disease.

  2012cites this paper
• Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

  2012influential citation
• Genomic damage in the progression of chronic kidney disease in rats.

  2011cites this paper
• Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes.

  2011cites this paper
• Inflammation and insulin resistance in uremia.

  2008cites this paper
• Bacterial product cantastim derived from Pseudomonas aeruginosa induces migration and maturation of dendritic cells.

  2007cites this paper
• Systemic inflammatory markers in patients with aortic sclerosis.

  2007cites this paper
• UNRESOLVED ISSUES IN DIALYSIS: Long‐Term Management of the Tunneled Venous Catheter

  2006cites this paper
• BEEINFLUSSUNG VON CHRONISCHER INFLAMMATION UND ENDOTHELIALER DYSFUNKTION BEI TERMINALER NIERENINSUFFIZIENZ DURCH EINE POLYMETHYLMETHACRYLAT- IM VERGLEICH ZU EINER HÄMOPHAN-DIALYSEMEMBRAN

  2006cites this paper
• A molecular microbial ecology approach to studying hemodialysis water and fluid.

  2006cites this paper
• Bacterial infections in hemodialysis patients: pathogenesis and prevention.

  2005cites this paper
• IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.

  2005cites this paper
• Chronic Kidney Disease: Need for an Integrated Therapy Against Malnutrition and Wasting

  2005cites this paper
• Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.

  2004cites this paper
• POOR NUTRITIONAL STATUS AND INFLAMMATION: Novel Approaches in an Integrated Therapy of Inflammatory‐Associated Wasting in End‐Stage Renal Disease

  2004cites this paper
• The biology of hemodialysis

  2004cites this paper
• Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis.

  2003cites this paper
• Effects of biofilm formation on haemodialysis monitor disinfection.

  2003cites this paper
• CHAPTER 28 – Interleukin-1 receptor antagonist [IL-1F3]

  2003cites this paper
• Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis.

  2002cites this paper
• Dialysis and Transplantation

  2001cites this paper
• High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.

  2001cites this paper
• response in human monocytes patients with severe sepsis or septic shock inhibit the lipopolysaccharide High concentrations of lipopolysaccharide-binding protein in serum of

  2001cites this paper